RESECTABLE GLIOBLASTOMA
Clinical trials for RESECTABLE GLIOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new RESECTABLE GLIOBLASTOMA trials appear
Sign up with your email to follow new studies for RESECTABLE GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for aggressive brain tumors? drug trial targets recurrent glioblastoma
Disease control Recruiting nowThis early-stage trial tests a new drug called ERAS-801 in 10 adults with a type of aggressive brain cancer (glioblastoma) that has come back or worsened. The drug targets a specific protein (EGFR) found on many of these tumor cells and is designed to reach the brain. The main go…
Matched conditions: RESECTABLE GLIOBLASTOMA
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated May 18, 2026 12:08 UTC
-
New hope for aggressive brain tumors: drug combo shows promise before surgery
Disease control Recruiting nowThis study tests two drugs, GI-102 and pembrolizumab, given before surgery to people whose aggressive brain cancer (glioblastoma) has returned. The goal is to see if these drugs can shrink the tumor and help the immune system fight the cancer. About 36 adults will take part, and …
Matched conditions: RESECTABLE GLIOBLASTOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Brain scan study aims to match right drug to right glioblastoma patient
Knowledge-focused Recruiting nowThis study uses MRI scans to look at brain tumor biology in 50 adults with glioblastoma that can be surgically removed. The goal is to find imaging markers that can predict which patients will benefit from the drug bevacizumab. Participants will have their tumors analyzed for a p…
Matched conditions: RESECTABLE GLIOBLASTOMA
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 04:32 UTC